- Home
- / Elos Medtech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Elos Medtech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
KR888.5 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SEK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|
| Revenue | 644.7M | 689.4M | 580.0M | 723.6M | 888.5M |
| Cost of goods sold | 423.8M | 429.7M | 343.5M | 422.0M | 522.0M |
| Gross profit | 222.4M | 261.6M | 237.6M | 304.8M | 368.7M |
| Gross profit margin, % | 34.5% | 38.0% | 41.0% | 42.1% | 41.5% |
| Operating expense total | 126.2M | 136.5M | 113.2M | 149.0M | 180.1M |
| Depreciation and amortization | 56.4M | 60.3M | 60.0M | 55.5M | 66.8M |
| EBITDA | 96.2M | 125.1M | 124.4M | 155.7M | 188.6M |
| EBITDA margin, % | 14.9% | 18.1% | 21.4% | 21.5% | 21.2% |
| EBIT | 39.4M | 65.6M | 64.0M | 100.6M | 121.6M |
| EBIT margin, % | 6.1% | 9.5% | 11.0% | 13.9% | 13.7% |
| Interest income | 86.0K | 87.0K | 97.0K | 398.0K | 878.0K |
| Interest expense | 11.0M | 12.7M | 12.4M | 10.5M | 21.1M |
| Pre tax profit | 28.5M | 50.6M | 43.3M | 98.0M | 99.1M |
| Income tax expense | 7.5M | 12.1M | 7.2M | 22.4M | 24.1M |
| Net Income | 20.9M | 38.5M | 36.0M | 75.6M | 75.1M |